500 Mg - 50 Ml Rituximab
500 Mg - 50 Ml Rituximab

500 Mg - 50 Ml Rituximab

Price 6500 INR/ Vial

MOQ : 1 Vial

500 Mg - 50 Ml Rituximab Specification

  • Dosage Form
  • Injection
  • Salt Composition
  • Rituximab 500 mg
  • Indication
  • Non-Hodgkins lymphoma, Chronic lymphocytic leukemia, Rheumatoid arthritis, Granulomatosis with polyangiitis, Microscopic polyangiitis
  • Enzyme Types
  • Monoclonal antibody (Not enzymatic)
  • Feature
  • High-purity recombinant antibody; standardized concentration, single-dose vial
  • Ingredients
  • Rituximab (Active), excipients as per label
  • Application
  • Intravenous infusion for cancer and autoimmune therapy
  • Ph Level
  • Approximately 6.5
  • Temperature Needed For Fermentation
  • Not applicable (manufactured via mammalian cell culture)
  • Physical Color/Texture
  • Clear to slightly opalescent, colorless to pale yellow solution
  • Fermentation Smell
  • Odorless
  • Enzymatic Activity
  • Not applicable; therapeutic monoclonal antibody
  • Storage Instructions
  • Store at 2C 8C. Do not freeze. Protect from light.
  • Shelf Life
  • 24 months
 
 

About 500 Mg - 50 Ml Rituximab



For a limited time, utilise the offer on 500 mg - 50 ml Rituximab, a marvelous monoclonal antibody crafted for flawless therapeutic impact. This lofty solution, presented as a clear to slightly opalescent, colorless to pale yellow vial, is formulated for intravenous infusion, ensuring precision in cancer and autoimmune therapy. Each high-purity, single-dose glass vial contains standardized Rituximab, ideal for conditions like Non-Hodgkins lymphoma and rheumatoid arthritis. Available only by prescription under medical supervision, seize this ephemeral opportunity to access a truly distinguished product.

Therapeutic Application & Versatile Use

500 Mg - 50 Ml Rituximab is widely applied for treating Non-Hodgkin's lymphoma, chronic lymphocytic leukemia, rheumatoid arthritis, granulomatosis with polyangiitis, and microscopic polyangiitis. Utilised as an intravenous infusion, it demonstrates efficacy in cancer therapy and autoimmune disorders. Its commercial uses span across hospitals, specialized clinics, and research institutions, owing to its high-purity formulation and reliable outcomes. Designed for professionals, this product exemplifies flawless performance in demanding medical environments.


Export Logistics, Delivery & Sample Policy

Our Rituximab 500 mg - 50 ml orders are processed through key FOB ports in India, ensuring prompt delivery and reliable arrival schedules. Main export markets include Asia, Africa, and the Middle East, with opportunities for wider international quotation fulfillment. Sample requests are evaluated per our expert sample policy, designed to balance regulatory requirements and customer satisfaction. Contact us for quotes and secure the swift arrival of this unparalleled pharmaceutical solution at your chosen destination.


FAQ's of 500 Mg - 50 Ml Rituximab:


Q: How is 500 mg - 50 ml Rituximab administered?

A: Rituximab 500 mg - 50 ml is administered via intravenous infusion under strict medical supervision, usually in a clinical or hospital setting.

Q: What conditions can be treated with this Rituximab formulation?

A: It is primarily indicated for Non-Hodgkin's lymphoma, chronic lymphocytic leukemia, rheumatoid arthritis, granulomatosis with polyangiitis, and microscopic polyangiitis.

Q: When should this medication be used?

A: This medication should be used according to a physician's prescription, typically following diagnosis of the relevant cancer or autoimmune disorder.

Q: Where should Rituximab be stored?

A: It must be stored at 2C-8C, not frozen, and protected from light to preserve its efficacy throughout its 24-month shelf life.

Q: What are the commercial benefits of this specific Rituximab vial?

A: This product offers high-purity standardization, single-dose convenience, and wide applicability in hospital, research, and clinical environments, ensuring optimal outcomes.

Q: How can I utilise the offer for this product?

A: You can access the limited-time offer by contacting the supplier, distributor, or exporter in India and requesting a quotation tailored to your needs.

Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

More Products in Anti Cancer Injection Category

Infliximab Powder For Concentrate Solution For Infusion

Infliximab Powder For Concentrate Solution For Infusion

Price 18000 INR / Vial

Minimum Order Quantity : 1 Vial

Dosage Form : Powder for concentrate solution for infusion

Salt Composition : Infliximab

Shelf Life : 2 years (unopened vial)

Indication : Treatment of rheumatoid arthritis, Crohns disease, ankylosing spondylitis, ulcerative colitis, psoriatic arthritis, and plaque psoriasis

4 Mg Zoledronic Acid Injection IP

4 Mg Zoledronic Acid Injection IP

Price 499 INR / Vial

Minimum Order Quantity : 1 Vial

Dosage Form : Injection (Lyophilized Powder for Solution)

Salt Composition : Zoledronic Acid 4 mg

Shelf Life : 24 months from manufacturing date

Indication : Treatment of osteoporosis, Pagets disease, hypercalcemia of malignancy, bone metastases

60 Mg Denosumab Solution Injection PFS

60 Mg Denosumab Solution Injection PFS

Price 9500 INR / Vial

Minimum Order Quantity : 1 Vial

Dosage Form : Solution for Injection in Prefilled Syringe (PFS)

Salt Composition : Denosumab 60 mg

Shelf Life : 36 months

Indication : Treatment of osteoporosis in postmenopausal women and men at increased risk of fractures; treatment of bone loss associated with hormone ablation in cancer

40 Mg Mitomycin Injection IP

40 Mg Mitomycin Injection IP

Price 499 INR / Vial

Minimum Order Quantity : 1 Vial

Dosage Form : Injection

Salt Composition : Mitomycin 40 mg

Shelf Life : 24 months from date of manufacture

Indication : Antineoplastic agent, used in cancer therapy including stomach, pancreatic, and bladder cancers



Back to top